Canada Gazette, Part I, Volume 148, Number 8: GOVERNMENT NOTICES

February 22, 2014

DEPARTMENT OF THE ENVIRONMENT

CANADIAN ENVIRONMENTAL PROTECTION ACT, 1999

Significant New Activity Notice No. 17420

Significant New Activity Notice

(Section 85 of the Canadian Environmental Protection Act, 1999)

Whereas the Minister of the Environment and the Minister of Health have assessed information in respect of the substance dodecanoic acid, 3-[[3-[[[2,2-dimethyl-3-[(1-oxododecyl)oxy] propylidene]amino]methyl]-3,5,5-trimethylcyclohexyl]imino]-2,2- dimethylpropyl ester, Chemical Abstracts Service Registry No. 932742-30-8, under section 83 of the Canadian Environmental Protection Act, 1999;

Whereas the substance is not specified on the Domestic Substances List;

And whereas the ministers suspect that a significant new activity in relation to the substance may result in the substance becoming toxic within the meaning of section 64 of the Canadian Environmental Protection Act, 1999,

Therefore, the Minister of the Environment indicates, pursuant to section 85 of the Canadian Environmental Protection Act, 1999, that subsection 81(4) of that Act applies with respect to the substance in accordance with the Annex.

LEONA AGLUKKAQ
Minister of the Environment

ANNEX

Information Requirements

(Section 85 of the Canadian Environmental Protection Act, 1999)

  1. In relation to the substance dodecanoic acid, 3-[[3-[[[2,2-dimethyl-3-[(1-oxododecyl)oxy]propylidene]amino]methyl]-3,5,5-trimethylcyclohexyl]imino]-2,2-dimethylpropyl ester, a significant new activity is the use of the substance in Canada in a quantity greater than 1 000 kg per calendar year in consumer products as defined in section 2 of the Canada Consumer Product Safety Act, where it is present in the consumer product in its unreacted form.
  2. The following information must be provided to the Minister at least 90 days before the commencement of the proposed significant new activity:
    • (a) a description of the significant new activity in relation to the substance;
    • (b) the anticipated annual quantity of the substance to be used in relation to the significant new activity;
    • (c) the information specified in paragraph 8(g) of Schedule 5 to the New Substances Notification Regulations (Chemicals and Polymers);
    • (d) the test data and a test report from a skin sensitization study in respect of the substance that establishes the concentration of the substance that will generate the minimal dose that will induce a stimulation of proliferation in draining lymph nodes that is threefold the negative control (EC3 value), conducted according to the methodology described in the Organisation for Economic Co-operation and Development (OECD) Test Guideline No. 429 titled Skin Sensitisation: Local Lymph Node Assay (Test Guideline); and
    • (e) all other information or test data in respect of the substance that are in the possession of the person proposing the significant new activity, or to which they have access, and that are relevant to determining whether the substance is toxic or capable of becoming toxic.
  3. The test data and the test report described in paragraph 2(d) must be in conformity with the practices described in the OECD Principles of Good Laboratory Practice (Principles of GLP) set out in Annex 2 of the Decision of the Council Concerning the Mutual Acceptance of Data in the Assessment of Chemicals, adopted on May 12, 1981, where the Test Guideline and Principles of GLP are current at the time the test data are developed.
  4. The above information will be assessed within 90 days after the day on which it is received by the Minister.

EXPLANATORY NOTE

(This explanatory note is not part of the Significant New Activity Notice.)

Experimental evidence considered in the assessment of the substance suggests the potential for skin sensitization. The local lymph node assay will allow the characterization of its skin sensitization potential. The Significant New Activity Notice was issued to obtain information to ensure that the substance will undergo further assessment if used in consumer products under certain conditions.

A Significant New Activity Notice is a legal instrument issued by the Minister of the Environment pursuant to section 85 of the Canadian Environmental Protection Act, 1999. The Significant New Activity Notice sets out the appropriate information that must be provided to the Minister for assessment prior to the commencement of a new activity as described in the Notice.

Substances that are not listed on the Domestic Substances List can be manufactured or imported only by the person who has met the requirements set out in section 81 of the Canadian Environmental Protection Act, 1999. Under section 86 of the Canadian Environmental Protection Act, 1999, in circumstances where a Significant New Activity Notice is issued for a new substance, it is the responsibility of every person who transfers the physical possession or control of the substance to notify all persons to whom the possession or control is transferred of the obligation to comply with the Significant New Activity Notice and of the obligation to notify the Minister of the Environment of any new activity and all other information as described in the Notice. It is the responsibility of the users of the substance to be aware of and comply with the Significant New Activity Notice and to submit a Significant New Activity notification to the Minister prior to the commencement of a significant new activity associated with the substance. However, as mentioned in subsection 81(6) of the Canadian Environmental Protection Act, 1999, a Significant New Activity notification is not required when the proposed new activity is regulated under an act or regulations listed on Schedule 2 to the Canadian Environmental Protection Act, 1999.

A Significant New Activity Notice does not constitute an endorsement from Environment Canada or the Government of Canada of the substance to which it relates, or an exemption from any other laws or regulations that are in force in Canada and that may apply to this substance or activities involving the substance.

A pre-notification consultation is an option for notifiers who wish to consult with the New Substances program during the planning or preparation of their Significant New Activity notification to discuss any questions or concerns they have about the required prescribed information and test plans.

[8-1-o]

DEPARTMENT OF HEALTH

HAZARDOUS MATERIALS INFORMATION REVIEW ACT

Decisions, undertakings and orders on claims for exemption

Pursuant to paragraph 18(1)(a) of the Hazardous Materials Information Review Act, the Chief Screening Officer of the Workplace Hazardous Materials Directorate hereby gives notice of the decisions of the screening officer, respecting each claim for exemption and the relevant material safety data sheet (MSDS) and (where applicable) the label, listed below.

In accordance with section 20 of the Hazardous Materials Information Review Act, a claimant or any affected party may appeal a decision or order of a screening officer. An affected party may also appeal an undertaking in respect of which a notice has been published in the Canada Gazette. “Affected party” means a person who is not a competitor of the claimant and who uses, supplies or is otherwise involved in the use or supply of the controlled product at a work place, and includes

To initiate the appeal process, a Statement of Appeal (Form 1) as prescribed by the Hazardous Materials Information Review Act Appeal Board Procedures Regulations must be completed and delivered, along with the fee prescribed by section 12 of the Hazardous Materials Information Review Regulations, within 45 days of the publication of this notice in the Canada Gazette, Part I, to the Chief Appeals Officer at the following address: Workplace Hazardous Materials Directorate, 427 Laurier Avenue West, 7th Floor, Ottawa, Ontario K1A 0K9.

STEPHANIE REID
Chief Screening Officer

Claimant Product Identifier (As shown on the MSDS) Registry Number Date of Decision
Schlumberger Canada Limited, Calgary, Alberta B293 Gelled Oil Gelling Agent 8250 2013-09-25
Afton Chemical Corporation, Richmond, Virginia HiTEC 2893 Performance Additive 8287 2013-05-31
MeadWestvaco Corporation, Covington, Virginia NUCHAR® WV-IS XL SPECIALTY TREATED ACTIVATED CARBON 8324 2013-05-31
3M Canada Company, London, Ontario 3M(TM) Anisotropic Conductive Film 7379 8325 2013-08-09
Canyon Technical Services, Calgary, Alberta CAN-LTC HT 8340 2013-07-24
Dow Corning Corporation, Midland, Michigan XIAMETER® Q2-3183A Antifoam 8342 2013-04-30
GE Water & Process Technologies Canada, Oakville, Ontario STYREX 3306 8352 2013-04-30
GE Water & Process Technologies Canada, Oakville, Ontario THERMOFLO 7004 8355 2013-04-30
Arkema Canada Inc., Burlington, Ontario THERMOLITE® 178 8421 2013-05-30
Sealed Air Corporation, Brampton, Ontario INSTAPAK QUICK® COMPONENT “B” 8440 2013-05-23
Sealed Air Corporation, Brampton, Ontario INSTAPAK® QUICK TUFF™ COMPONENT “B” 8441 2013-05-23
Sealed Air Corporation, Brampton, Ontario INSTAPAK FLOWRITE™ COMPONENT “B” 8443 2013-05-23
Sealed Air Corporation, Brampton, Ontario INSTAPAK® RC45 COMPONENT “B” 8444 2013-05-23
GE Water & Process Technologies Canada, Oakville, Ontario THERMOFLO 7008 8447 2013-08-30
GE Water & Process Technologies Canada, Oakville, Ontario THERMOFLO 7011 8448 2013-04-30
GE Water & Process Technologies Canada, Oakville, Ontario PROSWEET S1766 8449 2013-08-30
GE Water & Process Technologies Canada, Oakville, Ontario PROSWEET S1767 8450 2013-08-30
GE Water & Process Technologies Canada, Oakville, Ontario PHILMPLUS 5068 8451 2013-08-30
GE Water & Process Technologies Canada, Oakville, Ontario PHILMPLUS 5067 8452 2013-05-30
Momentive Specialty Chemicals, Inc., Oshawa, Ontario EPIKURE™ Curing Agent 3164 8469 2013-03-04
3M Canada Company, London, Ontario SCOTCHCAST RESIN 4 PART B 8473 2013-08-09
GE Water & Process Technologies Canada, Oakville, Ontario PHILMPLUS 5065 8474 2013-05-30
GE Water & Process Technologies Canada, Oakville, Ontario PHILMPLUS 5066 8475 2013-05-30
GE Water & Process Technologies Canada, Oakville, Ontario SPEC-AID 8Q206S 8476 2013-08-30
GE Water & Process Technologies Canada, Oakville, Ontario INHIBITOR SL8205 8477 2013-09-23
GE Water & Process Technologies Canada, Oakville, Ontario GENGARD GN8223 8478 2013-08-30
Oilflow Solutions Inc., Calgary, Alberta SI-114 8482 2013-08-23
BWA Water Additives US LLC, Tucker, Georgia BELGARD EV2050 8490 2013-06-13
BWA Water Additives US LLC, Tucker, Georgia DP8053 8491 2013-05-31
BWA Water Additives US LLC, Tucker, Georgia BELGARD EV2035 8492 2013-06-13
Guardian Chemicals Inc., Fort Saskatchewan, Alberta CROSSOVER 8494 2013-07-19
Nalco Canada Co., Burlington, Ontario NALCO® EC3003A 8495 2013-04-30
Nalco Canada Co., Burlington, Ontario NALCO® EC3205A 8496 2013-04-30
Nalco Canada Co., Burlington, Ontario COMPTRENE® EC3144B 8498 2013-09-17
Nalco Canada Co., Burlington, Ontario FORTIS® EC3062A 8500 2013-09-16
Nalco Canada Co., Burlington, Ontario MVP® EC9179A 8502 2013-08-23
Graffiti Solutions Canada, Ottawa, Ontario Citrus Blast Graffiti Remover 8506 2013-08-09
Graffiti Solutions Canada, Ottawa, Ontario Rhino Blast Graffiti Remover 8507 2013-08-09
Rohm and Haas Canada LP, West Hill, Ontario DRYCRYL™ DP-2903 Dispersible Powder 8511 2013-04-30
Rohm and Haas Canada LP, West Hill, Ontario PARALOID™ K-125 Processing Aid 8512 2013-04-30
GE Water & Process Technologies Canada, Oakville, Ontario PREDATOR MR2513 8514 2013-08-30
3M Canada Company, London, Ontario SCOTCHKOTE 6233 4G, 8G, and 11G FUSION BONDED EPOXY COATING 8515 2013-07-30
3M Canada Company, London, Ontario 3M™ Heavy Duty Wheel Cleaner PN 38374, 38375 8516 2013-07-30
Momentive Performance Materials, Markham, Ontario Niax® catalyst C-211 8524 2013-06-21
Momentive Performance Materials, Markham, Ontario Geolite® modifier HR 8525 2013-06-18
Nalco Canada Co., Burlington, Ontario NALCO® EC3053A 8529 2013-09-23
Nalco Canada Co., Burlington, Ontario COKE-LESS® EC3279A 8531 2013-09-24
Diversity Technologies Corp., Edmonton, Alberta TC 101 8534 2013-08-28
AVISTA Technologies Inc., San Marcos, California VITEC™ 3000 NSF 8535 2013-08-26
BYK USA Inc., Wallingford, Connecticut ANTI-TERRA-U 8536 2013-07-19
BYK USA Inc., Wallingford, Connecticut BYK-W 920 8537 2013-07-19
3M Canada Company, London, Ontario 3M™ SCOTCH-WELD™ EPOXY ADHESIVE DP-460 NS (Part A) 8541 2013-05-31
3M Canada Company, London, Ontario 3M™ SCOTCH-WELD™ EPOXY ADHESIVE 420 B/A, OFF-WHITE (Part A) 8544 2013-05-31
BASF Canada Inc., Mississauga, Ontario Plurafac® CS-10 8545 2013-07-24
Momentive Performance Materials, Markham, Ontario Niax* silicone L-560 8546 2013-07-08
Momentive Performance Materials, Markham, Ontario Silquest* PC-1A silane 8547 2013-08-29
Momentive Performance Materials, Markham, Ontario Niax* catalyst A-400 8550 2013-09-10
Momentive Performance Materials, Markham, Ontario Niax* Silicone L-2125 8552 2013-04-30
Momentive Performance Materials, Markham, Ontario Niax* Silicone U-2000 8553 2013-04-30
The Lubrizol Corporation, Wickliffe, Ohio LUBRIZOL® 5515A 8560 2013-06-25
Matrix Drilling Fluids Ltd., Calgary, Alberta MATRIX ASAP RESIN 8562 2013-07-19
Matrix Drilling Fluids Ltd., Calgary, Alberta MATRIX ASAP LTA ACTIVATOR 8563 2013-07-19
Matrix Drilling Fluids Ltd., Calgary, Alberta MATRIX ASAP HTA ACTIVATOR 8564 2013-07-19
Akzo Nobel Surface Chemistry LLC, Chicago, Illinois BEROL® 609 8565 2013-09-23
3M Canada Company, London, Ontario 3M™ Scotch-Weld™ Epoxy Adhesive 460 B/A, Off-White (Part A) 8566 2013-05-31
Chevron Oronite Company LLC, Bellaire, Texas OLOA 40000 8567 2013-09-25
Rohm and Haas Canada LP, West Hill, Ontario CR 9-101 8568 2013-09-30
BYK USA Inc., Wallingford, Connecticut BYK-W 995 8569 2013-07-19
BYK USA Inc., Wallingford, Connecticut DISPERBYK-110 8570 2013-07-19
ITW Philadelphia Resins, Montgomeryville, Pennsylvania CHOCKFAST BLACK RESIN 8571 2013-04-30
ITW Philadelphia Resins, Montgomeryville, Pennsylvania CHOCKFAST GRAY RESIN 8572 2013-04-30
BYK USA Inc., Wallingford, Connecticut BYK-W 990 8573 2013-07-19
BYK USA Inc., Wallingford, Connecticut DISPERBYK-106 8574 2013-07-19
BYK USA Inc., Wallingford, Connecticut DISPERBYK-140 8575 2013-07-19
BYK USA Inc., Wallingford, Connecticut DISPERBYK-142 8576 2013-07-19
Nalco Canada Co., Burlington, Ontario Nalco® EC6730A 8579 2013-07-09
E.I. du Pont Canada Company, Mississauga, Ontario Capstone® FS-3100 8585 2013-09-30
Cytec Industries Inc., Woodland Park, New Jersey BR® 6747-1 Water Based Primer, 20-40% Solids 8588 2013-09-13
Cytec Industries Inc., Woodland Park, New Jersey AEROSOL® OT-NV Surfactant 8589 2013-07-15
Nalco Canada Co., Burlington, Ontario NALCO® EC6595A 8597 2013-09-25
GE Water & Process Technologies Canada, Oakville, Ontario PREDATOR 3800 8606 2013-09-23
GE Water & Process Technologies Canada, Oakville, Ontario PREDATOR 3801 8607 2013-09-23
GE Water & Process Technologies Canada, Oakville, Ontario THERMOFLO 7012 8608 2013-09-23
Cytec Industries Inc., Woodland Park, New Jersey BR®1009-8 Tack Primer 8609 2013-09-19
3M Canada Company, London, Ontario 3M™ DEVELOPMENTAL MATERIAL AHS-1519 8613 2013-08-30
3M Canada Company, London, Ontario 3M™ DEVELOPMENTAL MATERIAL AHS-1523 8615 2013-07-30
Canyon Technical Services, Calgary, Alberta CAN-LTC 8622 2013-07-24
Innospec Fuel Specialties, Newark, Delaware Oil Color IAR Liquid Dye 8638 2013-08-26
Dow Chemical Canada ULC, Calgary, Alberta UCARSOL™ SOLVENT COMPONENT DHM 8646 2013-09-30
MeadWestvaco Corporation - Specialty Chemicals Division, North Charleston, South Carolina EVOTHERM™ M1 8652 2013-07-15
MeadWestvaco Corporation - Specialty Chemicals Division, North Charleston, South Carolina INDULIN® AA-86 8653 2013-07-15
Air Products & Chemicals, Inc., Allentown, Pennsylvania Tomamine® Amphoteric 12 Surfactant 8758 2013-09-19
BASF Canada Inc., Mississauga, Ontario Cromophtal Yellow D 1085 8778 2013-09-25

NOTES:

  1. The Notice of Filing published in the Canada Gazette, Part I, on July 30, 2011, listed the subject of the claim bearing Registry Number 8250 to be the chemical identity and information that could be used to identify a supplier of a controlled product of one ingredient. The subject of the claim on which the screening officer issued the decision is the chemical identity of four ingredients.
  2. The Notice of Filing published in the Canada Gazette, Part I, on September 24, 2011, listed the subject of the claim bearing Registry Number 8287 to be the chemical identity of two ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of four ingredients.
  3. The Notice of Filing published in the Canada Gazette, Part I, on December 3, 2011, for the claim bearing Registry Number 8340, listed the name of the claimant as Canyon Technical Services and the subject of the claim to be the chemical identity of two ingredients. The screening officer issued the decision on which the claimant name was Canyon Services Group Inc. and the subject of the claim was the chemical name, common name, generic name, trade name or brand name of a controlled product and information that could be used to identify a supplier of a controlled product.
  4. The Notice of Filing published in the Canada Gazette, Part I, on December 3, 2011, listed the subject of the claim bearing Registry Number 8342 to be the chemical identity of two ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of three ingredients.
  5. The Notice of Filing published in the Canada Gazette, Part I, on December 3, 2011, listed the subject of the claim bearing Registry Number 8352 to be the chemical identity and concentration of two ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity and concentration of one ingredient.
  6. The Notice of Filing published in the Canada Gazette, Part I, on February 18, 2012, listed the subject of the claim bearing Registry Number 8421 to be the chemical identity of two ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of one ingredient.
  7. The Notice of Filing published in the Canada Gazette, Part I, on February 18, 2012, listed the subject of the claim bearing Registry Number 8444 to be the chemical identity of three ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of two ingredients.
  8. The Notice of Filing published in the Canada Gazette, Part I, on February 18, 2012, listed the subject of the claim bearing Registry Number 8447 to be the chemical identity and concentration of four ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity and concentration of three ingredients.
  9. The Notice of Filing published in the Canada Gazette, Part I, on February 18, 2012, listed the subject of the claim bearing Registry Number 8448 to be the chemical identity and concentration of two ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity and concentration of one ingredient.
  10. The Notice of Filing published in the Canada Gazette, Part I, on February 18, 2012, listed the product identifier for the product bearing Registry Number 8469 to be EPIKURE™ 3164 Curing Agent. The product identifier for the product on which the screening officer issued the decision is EPIKURE™ Curing Agent 3164.
  11. The Notice of Filing published in the Canada Gazette, Part I, on February 18, 2012, listed the subject of the claim bearing Registry Number 8473 to be the chemical identity of two ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of four ingredients.
  12. The Notice of Filing published in the Canada Gazette, Part I, on February 18, 2012, listed the subject of the claim bearing Registry Number 8490 to be the chemical identity of three ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity and concentration of three ingredients.
  13. The Notice of Filing published in the Canada Gazette, Part I, on February 18, 2012, listed the subject of the claim bearing Registry Number 8491 to be the chemical identity of five ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity and concentration of four ingredients.
  14. The Notice of Filing published in the Canada Gazette, Part I, on February 18, 2012, listed the subject of the claim bearing Registry Number 8492 to be the chemical identity of two ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity and concentration of one ingredient.
  15. The Notice of Filing published in the Canada Gazette, Part I, on February 18, 2012, listed the subject of the claim bearing Registry Number 8495 to be the chemical identity of two ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of one ingredient.
  16. The Notice of Filing published in the Canada Gazette, Part I, on February 18, 2012, listed the subject of the claim bearing Registry Number 8496 to be the chemical identity of three ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of two ingredients.
  17. The Notice of Filing published in the Canada Gazette, Part I, on February 18, 2012, listed the subject of the claim bearing Registry Number 8498 to be the chemical identity of three ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of one ingredient.
  18. The Notice of Filing published in the Canada Gazette, Part I, on April 28, 2012, listed the subject of the claim bearing Registry Number 8512 to be the chemical identity of two ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of four ingredients.
  19. The Notice of Filing published in the Canada Gazette, Part I, on April 28, 2012, listed the subject of the claim bearing Registry Number 8529 to be the chemical identity of five ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of four ingredients.
  20. The Notice of Filing published in the Canada Gazette, Part I, on April 28, 2012, listed the product identifier for the product bearing Registry Number 8534 to be TC-101. The product identifier for the product on which the screening officer issued the decision is TC 101.
  21. The Notice of Filing published in the Canada Gazette, Part I, on April 28, 2012, for the product bearing Registry Number 8535, listed the product identifier to be Vitec® 3000 and the subject of the claim to be the chemical identity of three ingredients. The product identifier and the subject of the claim for the product on which the screening officer issued the decision are VITEC™ 3000 NSF and the chemical identity of two ingredients, respectively.
  22. The Notice of Filing published in the Canada Gazette, Part I, on April 28, 2012, listed the product identifier for the product bearing Registry Number 8545 to be Plurafac CS 10. The product identifier for the product on which the screening officer issued the decision is Plurafac® CS-10.
  23. The Notice of Filing published in the Canada Gazette, Part I, on April 28, 2012, listed the product identifier for the product bearing Registry Number 8546 to be Niax® Silicone L-560. The product identifier for the product on which the screening officer issued the decision is Niax* silicone L-560.
  24. The Notice of Filing published in the Canada Gazette, Part I, on April 28, 2012, listed the product identifier for the product bearing Registry Number 8550 to be Niax® catalyst A-400. The product identifier for the product on which the screening officer issued the decision is Niax* catalyst A-400.
  25. The Notice of Filing published in the Canada Gazette, Part I, on April 28, 2012, listed the product identifier for the product bearing Registry Number 8553 to be Niax® Silicone U-2000. The product identifier for the product on which the screening officer issued the decision is Niax* Silicone U-2000.
  26. The Notice of Filing published in the Canada Gazette, Part I, on April 28, 2012, listed the subject of the claim bearing Registry Number 8560 to be the chemical identity of three ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of two ingredients.
  27. The Notice of Filing published in the Canada Gazette, Part I, on April 28, 2012, listed the subject of the claim bearing Registry Number 8562 to be the chemical identity, concentration, chemical name, common name, generic name, trade name or brand name of a controlled product and information that could be used to identify a supplier of a controlled product of two ingredients and the name of a toxicological study of one ingredient. The subject of the claim on which the screening officer issued the decision is the chemical identity and concentration of one ingredient, the name of a toxicological study that identifies an ingredient of a controlled product, the chemical name, common name, generic name, trade name or brand name of a controlled product and information that could be used to identify a supplier of a controlled product.
  28. The Notice of Filing published in the Canada Gazette, Part I, on April 28, 2012, listed the subject of the claim bearing Registry Number 8563 to be the chemical identity, concentration, chemical name, common name, generic name, trade name or brand name of a controlled product and information that could be used to identify a supplier of a controlled product of two ingredients and the name of a toxicological study of one ingredient. The subject of the claim on which the screening officer issued the decision is the chemical identity and concentration of two ingredients, the name of a toxicological study that identifies ingredients of a controlled product, the chemical name, common name, generic name, trade name or brand name of a controlled product and information that could be used to identify a supplier of a controlled product.
  29. The Notice of Filing published in the Canada Gazette, Part I, on April 28, 2012, listed the subject of the claim bearing Registry Number 8564 to be the chemical identity, concentration, chemical name, common name, generic name, trade name or brand name of a controlled product and information that could be used to identify a supplier of a controlled product of two ingredients and the name of a toxicological study of one ingredient. The subject of the claim on which the screening officer issued the decision is the chemical identity and concentration of one ingredient, the name of a toxicological study that identifies an ingredient of a controlled product, the chemical name, common name, generic name, trade name or brand name of a controlled product and information that could be used to identify a supplier of a controlled product.
  30. The Notice of Filing published in the Canada Gazette, Part I, on April 28, 2012, listed the subject of the claim bearing Registry Number 8565 to be the chemical identity and concentration of two ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of three ingredients.
  31. The Notice of Filing published in the Canada Gazette, Part I, on April 28, 2012, listed the product identifier for the product bearing Registry Number 8570 to be Disperbyk-110. The product identifier for the product on which the screening officer issued the decision is DISPERBYK-110.
  32. The Notice of Filing published in the Canada Gazette, Part I, on April 28, 2012, listed the product identifier for the product bearing Registry Number 8574 to be Disperbyk-106. The product identifier for the product on which the screening officer issued the decision is DISPERBYK-106.
  33. The Notice of Filing published in the Canada Gazette, Part I, on April 28, 2012, listed the product identifier for the product bearing Registry Number 8575 to be Disperbyk-140. The product identifier for the product on which the screening officer issued the decision is DISPERBYK-140.
  34. The Notice of Filing published in the Canada Gazette, Part I, on April 28, 2012, listed the product identifier for the product bearing Registry Number 8576 to be Disperbyk-142. The product identifier for the product on which the screening officer issued the decision is DISPERBYK-142.
  35. The Notice of Filing published in the Canada Gazette, Part I, on June 30, 2012, listed the product identifier for the product bearing Registry Number 8585 to be Capstone FS-3100. The product identifier for the product on which the screening officer issued the decision is Capstone® FS-3100.
  36. The Notice of Filing published in the Canada Gazette, Part I, on June 30, 2012, listed the subject of the claim bearing Registry Number 8588 to be the chemical identity of five ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of four ingredients.
  37. The Notice of Filing published in the Canada Gazette, Part I, on June 30, 2012, for the claim bearing Registry Number 8622, listed the name of the claimant as Canyon Technical Services. The screening officer issued the decision on which the claimant name was Canyon Technical Services Ltd.
  38. The Notice of Filing published in the Canada Gazette, Part I, on February 23, 2013, for the product bearing Registry Number 8778, listed the product identifier to be Cromophtal® Yellow D1085 and the subject of the claim to be the chemical identity of two ingredients. The product identifier and the subject of the claim for the product on which the screening officer issued the decision are Cromophtal Yellow D1085 and the chemical identity of one ingredient, respectively.

There were no written representations from affected parties to the screening officer with respect to any of the above-mentioned claims for exemption and related MSDSs or labels.

Each of the claims for exemption listed above was found to be valid. The screening officer reached this decision after reviewing the information in support of the claim, having regard exclusively to the criteria found in section 3 of the Hazardous Materials Information Review Regulations.

Having regard for the various data readily available in the literature and any information provided by the claimant, the screening officer found that the respective MSDSs in respect of the claims bearing Registry Numbers 8340, 8492, 8511, 8512, 8536, 8537, 8552, 8553, 8567, 8573, 8589, 8622 and 8646 complied with the applicable requirements of the Hazardous Products Act and the Controlled Products Regulations.

In the case of the claims bearing Registry Numbers 8250, 8562, 8563 and 8564, being claims from an employer with operations in the province of Alberta, the screening officer found that the MSDSs and label(s) in respect of which the claims were filed did not comply with the applicable disclosure requirements of the Occupational Health and Safety Code 2009 of the Province of Alberta.

In all cases where the MSDS or the label was determined not to be in compliance with the relevant legislation, the screening officer offered the claimant the possibility of entering into an undertaking whereby the claimant would voluntarily make the changes necessary to bring the MSDS or the label into compliance. Pursuant to subsection 16.1(1) of the Hazardous Materials Information Review Act, the claimant was given 30 days to provide the screening officer with a signed undertaking accompanied by the MSDS or the label amended as necessary.

In the case of the following claims, the claimant supplied the screening officer with a signed undertaking accompanied by the MSDS or label amended as necessary within the time frame specified. The screening officer was satisfied that the claimant had taken the measures set out in the undertaking in the manner and within the period specified therein.

CLAIMS FOR WHICH THE SCREENING OFFICER WAS SATISFIED THAT THE CLAIMANT HAD TAKEN THE MEASURES SET OUT IN THE UNDERTAKING

Pursuant to paragraph 18(1)(b) of the Hazardous Materials Information Review Act, the Chief Screening Officer of the Workplace Hazardous Materials Directorate hereby gives notice of information that has been disclosed on the relevant MSDS or label in compliance with an undertaking.

Registry Number 8287

Date of notice confirming acceptance: June 20, 2013

The claimant had been advised to amend the MSDS as indicated below.

  1. Disclose that ingestion of an ingredient in the controlled product has been shown to cause central nervous system (CNS) effects in laboratory animals.
  2. Disclose the presence of two additional confidential hazardous ingredients in the controlled product in an acceptable manner.

Registry Number 8324

Date of notice confirming acceptance: August 22, 2013

The claimant had been advised to amend certain aspects of the content of the MSDS.

Registry Number 8325

Date of notice confirming acceptance: September 10, 2013

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Add oxides of nitrogen to the list of hazardous decomposition products.
  2. Disclose that chronic inhalation of an ingredient in the controlled product has been shown to cause lung fibrosis in laboratory animals.
  3. Disclose that an ingredient in the controlled product has been shown to cause mutagenic effects, in vitro.

Registry Number 8342

Date of notice confirming acceptance: December 12, 2013

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose the presence of an additional confidential hazardous ingredient in the controlled product in an acceptable manner.
  2. Disclose an LD50 (oral, rat) value of 1.06 mL/kg for the confidential hazardous ingredient “octylphenoxy polyethoxy ethanol”.
  3. Disclose that the hazardous ingredient “octylphenoxy polyethoxy ethanol” in the controlled product has been shown to cause skin sensitization in laboratory animals.

Registry Number 8421

Date of notice confirming acceptance: June 13, 2013

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose an LC50 (aerosol, rat, 4 hours) value of 2 180 mg/m3 for the hazardous ingredient “distillates, petroleum, hydrotreated light naphthenic”.
  2. Disclose an LD50 (oral, rat) value of 1 246 mg/kg and an LD50 (dermal, rabbit) value of 2.14 mL/kg for the hazardous ingredient “4-nonylphenol, branched”.
  3. Disclose that an ingredient in the controlled product has been shown to cause eye corrosion in laboratory animals.
  4. In relation to the first aid information shown on the MSDS for eye contact, disclose an approximate flush time of 30 minutes.

Registry Numbers 8440, 8441, 8443 and 8444

Date of notice confirming acceptance: December 11, 2013

The claimant had been advised to amend the MSDS and label as indicated below.

  1. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give plenty of water to drink.

Registry Number 8447

Date of notice confirming acceptance: September 13, 2013

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Add oxides of sulphur to the list of hazardous decomposition products.

Registry Number 8449

Date of notice confirming acceptance: September 17, 2013

The claimant had been advised to amend the MSDS as indicated below.

  1. Disclose that ingestion of an ingredient in the controlled product has been shown to cause liver effects in laboratory animals.
  2. Disclose that acute ingestion of an ingredient in the controlled product has been shown to cause immediate effects and death in the absence of medical intervention in humans.
  3. Disclose an ACGIH TVL–SEN Exposure Limit of 0.1 mg/m3 for the hazardous ingredient “aliphatic aldehyde”.
  4. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D1B.

Registry Number 8450

Date of notice confirming acceptance: September 17, 2013

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose that ingestion of an ingredient in the controlled product has been shown to cause liver effects in laboratory animals.
  2. Disclose an LD50 (oral, rat) value of 762 mg/kg and LC50 (aerosol, rat, 4 hours) value of 2.41 mg/L for the hazardous ingredient “aliphatic aldehyde”.
  3. Disclose that acute ingestion of an ingredient in the controlled product has been shown to cause immediate effects and death in the absence of medical intervention in humans.
  4. Disclose an ACGIH TVL–SEN Exposure Limit of 0.1 mg/m3 for the hazardous ingredient “aliphatic aldehyde”.
  5. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D1B, D2A and D2B.

Registry Number 8451

Date of notice confirming acceptance: September 13, 2013

The claimant had been advised to amend certain aspects of the content of the MSDS.

Registry Number 8452

Date of notice confirming acceptance: June 18, 2013

The claimant had been advised to amend certain aspects of the content of the MSDS.

Registry Number 8469

Date of notice confirming acceptance: August 29, 2013

The claimant had been advised to amend certain aspects of the content, format and wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Add oxides of carbon and oxides of nitrogen to the list of hazardous combustion products.
  2. Disclose an LD50 (oral, rat) value of 460 mg/kg for the confidential hazardous ingredient “alkyletheramine”.

Registry Number 8473

Date of notice confirming acceptance: September 10, 2013

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose the presence of two additional confidential hazardous ingredients in the controlled product in an acceptable manner.
  2. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that medical attention must be obtained immediately.
  3. In relation to the first aid information shown on the MSDS for skin contact, disclose an approximate flush time of 30 minutes and that medical attention must be obtained immediately.
  4. In relation to the first aid information shown on the MSDS for ingestion, disclose advice such as the following: should vomiting occur naturally, have the casualty lean forward in order to reduce the risk of aspiration; that if the casualty is rapidly losing consciousness, convulsing or is unconscious, vomiting should not be induced and fluids should not be offered to drink, and that medical attention must be obtained immediately.
  5. Disclose an LD50 (dermal, rabbit) value of 2 040 mg/kg for the hazardous ingredient “phenol, 4-nonyl-, branched”.
  6. Disclose an LD50 (dermal, rabbit) value of 870 mg/kg for the hazardous ingredient “N-aminoethylpiperazine”.
  7. Disclose an LD50 (dermal, rabbit) value of 550 mg/kg for the hazardous ingredient “triethylenetetramine”.
  8. Disclose that an ingredient in the controlled product has been shown to cause mutagenic effects in bacteria.

Registry Number 8474

Date of notice confirming acceptance: June 18, 2013

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Add oxides of nitrogen to the list of hazardous decomposition products.

Registry Number 8475

Date of notice confirming acceptance: June 18, 2013

The claimant had been advised to amend certain aspects of the content of the MSDS.

Registry Number 8476

Date of notice confirming acceptance: September 23, 2013

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose that an ingredient in the controlled product can be corrosive to the eyes and skin.
  2. Disclose an LD50 (oral, rat) value of 901 mg/kg for the confidential hazardous ingredient “(E44G) substituted phenol”.
  3. In relation to the first aid information shown on the MSDS for skin contact, disclose an approximate flush time of 30 minutes and that medical attention must be obtained immediately.
  4. In relation to the first aid information shown on the MSDS for eye contact, disclose an approximate flush time of 30 minutes.
  5. In relation to the first aid information shown on the MSDS for ingestion, disclose advice such as the following: should vomiting occur naturally, have the casualty lean forward in order to reduce the risk of aspiration.
  6. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class E.

Registry Number 8477

Date of notice confirming acceptance: October 7, 2013

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. In relation to the first aid information shown on the MSDS for eye and skin contact, disclose an approximate flush time of 30 minutes.
  2. In relation to the first aid information shown on the MSDS for ingestion, disclose advice such as the following: should vomiting occur naturally, have casualty lean forward in order to reduce the risk of aspiration.

Registry Number 8478

Date of notice confirming acceptance: September 13, 2013

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to dilute contents of stomach using 4–10 fluid ounces of milk or water.
  2. Add oxides of nitrogen to the list of hazardous decomposition products.

Registry Number 8482

Date of notice confirming acceptance: September 11, 2013

The claimant had been advised to amend certain aspects of the content and format of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. In relation to the first aid information shown on the MSDS for ingestion, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped and that medical attention must be obtained immediately.
  2. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give two to four glasses of water to drink.
  3. Disclose a statement to the effect that metal containers should be grounded during the transfer of large quantities of the controlled product; that ignition sources should be avoided or eliminated when working with the controlled product and the product stored away from ignition sources and heat; and that if ventilation is inadequate, vapours can spread from open containers of the product and may flash back, causing a fire if they contact an ignition source.
  4. Disclose an ACGIH TLV–TWA Exposure Limit of 200 ppm and an ACGIH TLV–STEL Exposure Limit of 250 ppm with skin notation for the hazardous ingredient “methanol”.
  5. Disclose an ACGIH TLV–STEL Exposure Limit of 1 000 ppm for the hazardous ingredient “ethanol”.
  6. Disclose that the hazardous ingredient “ethanol” has been classified as a suspected human carcinogen (A3) by the American Conference of Governmental Industrial Hygienists (ACGIH).
  7. Add oxides of carbon to the list of hazardous decomposition products.
  8. Disclose an LD50 (oral, rat) value of >50–500 mg/kg and an LD50 (dermal, rat) value of >200–1 000 mg/kg for the confidential hazardous ingredient “aliphatic ammonium salt”.
  9. Disclose an LD50 (oral, rat) value of 9 690 mg/kg for the hazardous ingredient “methanol”.
  10. Disclose an LD50 (oral, rat) value of 10 470 mg/kg and an LC50 (vapour, male rat, 4 hours) value of 117 mg/L for the hazardous ingredient “ethanol”.
  11. Disclose that hazardous ingredients in the controlled product have been shown to cause teratogenic and fetotoxic effects in humans and in laboratory animals.
  12. Disclose that chronic consumption of an ingredient in the controlled product has been shown to cause impairment in the reproductive functions in male rats.
  13. Disclose that an ingredient in the controlled product has been shown to cause synergistic effects with “N-butyraldoxime”, and drowsiness, shortness of breath and palpitations in humans.

Registry Number 8490

Date of notice confirming acceptance: December 13, 2013

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. In relation to the first aid information shown on the MSDS for eye contact, disclose an approximate flush time of 30 minutes and that medical attention must be obtained immediately.

Registry Number 8491

Date of notice confirming acceptance: July 15, 2013

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose that ingredients in the controlled product have been shown to cause serious injury to the eyes.
  2. In relation to the first aid information shown on the MSDS for eye contact, disclose an approximate flush time of 30 minutes and that medical attention must be obtained immediately.
  3. Disclose the acute lethality values with greater precision.

Registry Number 8494

Date of notice confirming acceptance: August 20, 2013

The claimant had been advised to amend the MSDS as indicated below.

  1. Disclose an LD50 (oral, rat) value for the confidential hazardous ingredient “amino alcohol” in an acceptable manner.
  2. Disclose that an ingredient in the controlled product has been shown to cause eye corrosion in laboratory animals.
  3. In relation to the first aid information shown on the MSDS for eye contact, disclose an approximate flush time of 30 minutes.

Registry Numbers 8495 and 8496

Date of notice confirming acceptance: May 15, 2013

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose that dermal exposure to an ingredient in the controlled product has been shown to cause central nervous system (CNS) effects in laboratory animals.
  2. Disclose that an ingredient in the controlled product has been shown to cause mutagenic effects in human and mammalian somatic cells.

Registry Number 8498

Date of notice confirming acceptance: October 18, 2013

The claimant had been advised to amend the MSDS as indicated below.

  1. Disclose an LD50 (oral, rat) value of 7 050 mg/kg for the hazardous ingredient “heavy aromatic naphtha”.

Registry Number 8500

Date of notice confirming acceptance: October 8, 2013

The claimant had been advised to amend the MSDS as indicated below.

  1. Disclose that exposure to an ingredient in the controlled product has been shown to cause teratogenic effects in the presence of maternal toxicity in laboratory animals.

Registry Number 8502

Date of notice confirming acceptance: September 20, 2013

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose an ACGIH TLV–TWA Exposure Limit of 100 ppm for the hazardous ingredient “Stoddard solvent”.

Registry Number 8506

Date of notice confirming acceptance: September 11, 2013

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. In relation to the first aid information shown on the MSDS for eye and skin contact, disclose a statement to the effect that medical attention must be obtained immediately.
  2. Disclose a statement to the effect that metal containers should be grounded during the transfer of large quantities of the controlled product; that ignition sources should be avoided or eliminated when working with the controlled product; and that if ventilation is inadequate, vapours can spread from open containers of the product and may flash back, causing a fire if they contact an ignition source.
  3. Disclose a lower LD50 (oral, rat) value of 3 002 mg/kg for the hazardous ingredient “diacetone alcohol” or a calculated product LD50 (oral, rat) value of 2 354 mg/kg.
  4. Disclose an LD50 (oral, rat) value for all hazardous ingredients in an acceptable manner, or a calculated product LD50 (dermal, rabbit) value of >2 413 mg/kg.
  5. Disclose that the hazardous ingredient “D-Limonene” in the controlled product has been shown to cause skin sensitization in laboratory animals.

Registry Number 8507

Date of notice confirming acceptance: September 10, 2013

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. In relation to the first aid information shown on the MSDS for eye and skin contact, disclose a statement to the effect that medical attention must be obtained immediately.

Registry Number 8514

Date of notice confirming acceptance: September 13, 2013

The claimant had been advised to amend certain aspects of the format of the MSDS.

Registry Number 8515

Date of notice confirming acceptance: September 13, 2013

The claimant had been advised to amend the MSDS as indicated below.

  1. In relation to the first aid information shown on the MSDS for eye and skin contact, disclose an approximate flush time of 20 minutes.
  2. Add “hydrogen chloride” to the list of hazardous combustion products.
  3. Disclose an LD50 (oral, rat) value of 11.4 g/kg for the hazardous ingredient “Bisphenol A Diglycidyl Ether-Bisphenol A Copolymer”.
  4. Disclose that ingredients in the controlled product have been shown to cause mutagenic effects in mammalian cells and bacteria, in vitro.

Registry Number 8516

Date of notice confirming acceptance: September 4, 2013

The claimant had been advised to amend the MSDS as indicated below.

  1. In relation to the first aid information shown on the MSDS for skin contact, disclose an approximate flush time of 30 minutes and that medical attention must be obtained immediately.
  2. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give two glasses of water to drink.
  3. In relation to the first aid information shown on the MSDS for ingestion, disclose advice such as the following: should vomiting occur naturally, have the casualty lean forward in order to reduce the risk of aspiration.
  4. Add “hydrogen chloride” to the list of hazardous combustion products.
  5. Disclose an LD50 (oral, rat) value of 130 mg/kg for the hazardous ingredient “ammonium biflouride”.

Registry Number 8524

Date of notice confirming acceptance: July 29, 2013

The claimant had been advised to amend certain aspects of the content and wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. If the WHMIS classifications and pictograms are stated on the MSDS, disclose that the controlled product is also in class E and disclose the E pictogram.
  2. Disclose that ingredients in the controlled product have been shown to cause skin corrosion.
  3. Disclose inhalation as a route of exposure.
  4. In relation to the first aid information shown on the MSDS for ingestion, disclose a statement to the effect that if the casualty is rapidly losing consciousness, convulsing or is unconscious, vomiting should not be induced and fluids should not be offered to drink; should vomiting occur naturally, have the casualty lean forward in order to reduce the risk of aspiration, and obtain medical attention immediately.
  5. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that contaminated clothing, shoes and leather goods should be removed under running water and that medical attention must be obtained immediately.
  6. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that the eyes should be flushed with gently flowing water for at least 30 minutes.
  7. Disclose that exposure to an ingredient in the controlled product has been shown to cause teratogenic effects in the presence of maternal toxicity in laboratory animals.

Registry Number 8525

Date of notice confirming acceptance: July 29, 2013

The claimant had been advised to amend certain aspects of the wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose an LD50 (dermal, rabbit) value of >500 mg/kg for the confidential hazardous ingredient “alcohol amine”.

Registry Number 8529

Date of notice confirming acceptance: October 31, 2013

The claimant had been advised to amend certain aspects of the wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose that chronic oral exposure of an ingredient in the controlled product has been shown to cause liver effects in laboratory animals.
  2. Disclose that acute oral exposure of an ingredient in the controlled product has been shown to cause central nervous system (CNS) effects in laboratory animals.
  3. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that skin should be washed with soap and flowing water for at least 30 minutes.
  4. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D1B.

Registry Number 8531

Date of notice confirming acceptance: October 31, 2013

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. In relation to the first aid information shown on the MSDS for dermal exposure, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped.

Registry Number 8534

Date of notice confirming acceptance: September 19, 2013

The claimant had been advised to amend the MSDS as indicated below.

  1. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that medical attention must be obtained immediately.
  2. In relation to the first aid information shown on the MSDS for ingestion, disclose a statement to the effect that if the casualty is rapidly losing consciousness, convulsing or is unconscious, vomiting should not be induced and fluids should not be offered to drink.

Registry Number 8535

Date of notice confirming acceptance: September 30, 2013

The claimant had been advised to amend certain aspects of the format of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class E.
  2. In relation to the first aid information shown on the MSDS for skin contact, disclose an approximate flush time of 60 minutes.
  3. In relation to the first aid information shown on the MSDS for eye contact, disclose an approximate flush time of 60 minutes and that medical attention must be obtained immediately.
  4. Disclose the Exposure Limit Value ACGIH TLV–TWA = 10 mg/m3 for the confidential hazardous ingredient “Phosphonic acid derivative compound”.
  5. Disclose that the controlled product is incompatible with some chlorinated solvents, aluminum and zinc.

Registry Numbers 8541 and 8566

Date of notice confirming acceptance: June 20, 2013

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Add “hydrogen chloride” to the list of hazardous combustion products.

Registry Number 8544

Date of notice confirming acceptance: June 20, 2013

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Add “hydrogen chloride” to the list of hazardous combustion products.
  2. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give two glasses of water to drink and add a statement to the effect that medical attention should be obtained.

Registry Number 8545

Date of notice confirming acceptance: December 5, 2013

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Add oxides of carbon to the list of hazardous combustion products.

Registry Number 8546

Date of notice confirming acceptance: December 13, 2013

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Add inhalation as a route of entry.

Registry Number 8547

Date of notice confirming acceptance: September 25, 2013

The claimant had been advised to amend certain aspects of the content and wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. In relation to the first aid information shown on the MSDS for eye contact, disclose an approximate flush time of 30 minutes while holding the eyelids open.
  2. Disclose an ACGIH TLV–TWA Exposure Limit of 200 ppm and an ACGIH TLV–STEL Exposure Limit of 250 ppm with skin notation for the hazardous ingredient “methanol”.
  3. Disclose an AIHA WEEL–TWA value of 1 mg/m3 , an LD50 (oral, rat) value of >500 mg/kg, and an LD50 (dermal, rabbit) value of >1 000 mg/kg for the confidential hazardous ingredient “alkylpolyol polyalkenylate ester”.
  4. Disclose that an ingredient in the controlled product has been shown to cause mutagenic effects in mammalian cells, in vitro.

Registry Number 8550

Date of notice confirming acceptance: September 25, 2013

The claimant had been advised to amend certain aspects of the content and wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. In relation to the first aid information shown on the MSDS for ingestion, disclose advice such as the following: should vomiting occur naturally, have the casualty lean forward in order to reduce the risk of aspiration and obtain medical attention immediately.
  2. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that contaminated clothing, shoes and leather goods should be removed under running water and that medical attention must be obtained immediately.
  3. In relation to the first aid information shown on the MSDS for inhalation, disclose a statement to the effect that medical attention must be obtained immediately.
  4. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that the eyes should be rinsed continuously with gently flowing water for at least 30 minutes.
  5. Add oxides of nitrogen to the list of hazardous combustion and decomposition products.

Registry Number 8560

Date of notice confirming acceptance: July 11, 2013

The claimant had been advised to amend certain aspects of the content and wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose an LD50 (oral, rat) value for the controlled product.
  2. Disclose that an ingredient in the controlled product has been shown to cause mutagenic effects in bacteria, in the absence and/or presence of metabolic activation, in vitro.

Registry Number 8562

Date of notice confirming acceptance: September 5, 2013

The claimant had been advised to amend certain aspects of the content, format and wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose an LD50 (oral, rat) value of >5 000 mg/kg for the confidential hazardous ingredient “epoxy resin”.
  2. Disclose that an ingredient in the controlled product has been shown to cause mutagenic effects in mammalian cells and bacteria, in vitro.
  3. Add oxides of carbon to the list of hazardous decomposition products.
  4. Disclose the appropriate hazard symbol for a material causing other toxic effects on the label.

Registry Number 8563

Date of notice confirming acceptance: September 5, 2013

The claimant had been advised to amend certain aspects of the content, format and wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. If the WHMIS classifications are stated on the MSDS and label, disclose that the controlled product is also in class E.
  2. Disclose an LD50 (oral, rat) value and an LD50 (dermal, rabbit) value for the confidential hazardous ingredient “amine B” in an acceptable manner.
  3. Disclose the AIHA WEEL Exposure Limit Value of 1 ppm with a skin notation for the confidential hazardous ingredient “amine B”.
  4. Disclose that an ingredient in the controlled product has been shown to cause skin corrosion in laboratory animals.
  5. Disclose that an ingredient in the controlled product has been shown to cause mutagenic effects in mammalian cells and bacteria, in vitro.
  6. In relation to the first aid information shown on the MSDS and label for skin contact, disclose an approximate flush time of 30 minutes.
  7. In relation to the first aid information shown on the MSDS and label for ingestion, disclose advice such as the following: should vomiting occur naturally, have the casualty lean forward in order to reduce the risk of aspiration.
  8. Disclose the appropriate hazard symbol for a material causing immediate and serious toxic effects and the hazard symbol for a corrosive substance on the label.

Registry Number 8564

Date of notice confirming acceptance: September 5, 2013

The claimant had been advised to amend certain aspects of the content, format and wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose an LD50 (oral, rat) value for the confidential hazardous ingredient “amine” in an acceptable manner.
  2. Disclose that an ingredient in the controlled product has been shown to cause mutagenic effects in mammalian cells and bacteria, in vitro.
  3. Disclose the appropriate hazard symbol for a material causing immediate and serious toxic effects on the label.

Registry Number 8565

Date of notice confirming acceptance: October 28, 2013

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose an LD50 (oral, rat) value of 1.35 g/kg for the confidential hazardous ingredient “ethoxylated alcohol 1”.

Registry Numbers 8569 and 8570

Date of notice confirming acceptance: December 2, 2013

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose that ingestion of an ingredient in the controlled product has been shown to cause central nervous system (CNS) effects in laboratory animals.

Registry Number 8571

Date of notice confirming acceptance: June 20, 2013

The claimant had been advised to amend certain aspects of the wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose an ACGIH TVL–TWA Exposure Limit of 3 mg/m3 for the hazardous ingredient “carbon black” and show that “carbon black” has been classified as a suspected human carcinogen (A3) by the American Conference of Governmental Industrial Hygienists (ACGIH) and classified as a Group 2B by the International Agency for Research on Cancer (IARC).
  2. Disclose that the ingredient “crystalline silica” has been classified as a suspected human carcinogen (A2) by the American Conference of Governmental Industrial Hygienists (ACGIH) and classified as a Group 1 by the International Agency for Research on Cancer (IARC).
  3. Add oxides of carbon and hydrogen chloride to the list of hazardous decomposition products.
  4. Disclose that an ingredient in the controlled product has been shown to cause mutagenic effects in mammalian cells, in vitro.

Registry Number 8572

Date of notice confirming acceptance: June 20, 2013

The claimant had been advised to amend certain aspects of the content and wording of the MSDS and the content of the label. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose the International Agency for Research on Cancer (IARC) Group 2B classification for the hazardous ingredient “titanium dioxide”.
  2. Disclose an ACGIH TVL–TWA Exposure Limit of 3 mg/m3 for the hazardous ingredient “carbon black” and show that “carbon black” has been classified as a suspected human carcinogen (A3) by the American Conference of Governmental Industrial Hygienists (ACGIH) and classified as a Group 2B by the International Agency for Research on Cancer (IARC).
  3. Disclose that the ingredient “crystalline silica” has been classified as a suspected human carcinogen (A2) by the American Conference of Governmental Industrial Hygienists (ACGIH) and classified as a Group 1 by the International Agency for Research on Cancer (IARC).
  4. Add oxides of carbon and hydrogen chloride to the list of hazardous decomposition products.
  5. Disclose that an ingredient in the controlled product has been shown to cause mutagenic effects in mammalian cells, in vitro.

Registry Number 8574

Date of notice confirming acceptance: December 2, 2013

The claimant had been advised to amend certain aspects of the content of the MSDS.

Registry Number 8575

Date of notice confirming acceptance: December 2, 2013

The claimant has been advised to amend the MSDS as indicated below.

  1. Disclose an LD50 (oral, female rat) value of 5 155 mg/kg for the hazardous ingredient “1-methyloxy-2-propyl acetate”.

Registry Number 8579

Date of notice confirming acceptance: July 30, 2013

The claimant had been advised to amend certain aspects of the wording of the MSDS.

Registry Number 8585

Date of notice confirming acceptance: October 11, 2013

The claimant had been advised to amend certain aspects of the content and format of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose an ACGIH TLV–TWA Exposure Limit of 20 ppm for the hazardous ingredient “1,4-dioxane”.

Registry Number 8588

Date of notice confirming acceptance: October 15, 2013

The claimant had been advised to amend the MSDS as indicated below.

  1. In relation to the first aid information shown on the MSDS for inhalation, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped and that medical attention must be obtained immediately.
  2. Add “hydrogen chloride” to the list of hazardous decomposition products.
  3. Disclose an LC50 (aerosol, rat, 4 hours) value of 0.27–0.51 mg/L for the hazardous ingredient “strontium chromate”.
  4. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D1A or D1B.

Registry Number 8597

Date of notice confirming acceptance: October 18, 2013

The claimant had been advised to amend the MSDS as indicated below.

  1. Disclose that an ingredient in the controlled product has been shown to cause eye corrosion in laboratory animals.
  2. Disclose that both acute inhalation of and acute dermal exposure to an ingredient in the controlled product have been shown to cause adverse CNS effects in laboratory animals.
  3. Disclose an LD50 (oral, male rat) value of >50–500 mg/kg, an LD50 (dermal, rabbit) value of >200–1 000 mg/kg, and an LC50 (aerosol, rat, 1 hour) value of >0.5–2.5 mg/L for the confidential hazardous ingredient “quaternary phosphorus compound”.
  4. In relation to the first aid information shown on the MSDS for eye contact, disclose an approximate flush time of 30 minutes.
  5. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give water to drink.

Registry Numbers 8606 and 8607

Date of notice confirming acceptance: October 7, 2013

The claimant had been advised to amend certain aspects of the wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose that an ingredient in the controlled product is a skin irritant.
  2. In relation to the first aid information shown on the MSDS for skin contact, disclose an approximate flush time of 20 minutes and that medical attention must be obtained immediately.
  3. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D2B.

Registry Number 8608

Date of notice confirming acceptance: October 7, 2013

The claimant had been advised to amend certain aspects of the wording of the MSDS.

Registry Number 8609

Date of notice confirming acceptance: November 8, 2013

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give two glasses of water to drink.
  2. Disclose that if ventilation is inadequate, vapours can spread from open containers of the product and may flash back, causing a fire if they contact an ignition source.

Registry Number 8613

Date of notice confirming acceptance: September 17, 2013

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give two glasses of water to drink.
  2. Add oxides of nitrogen to the list of hazardous combustion products.
  3. Disclose that an ingredient in the controlled product has been shown to cause teratogenic effects in the presence of maternal toxicity in laboratory animals.

Registry Number 8615

Date of notice confirming acceptance: August 26, 2013

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give two glasses of water to drink.
  2. Disclose that an ingredient in the controlled product has been shown to cause adverse reproductive effects in the absence of maternal toxicity in laboratory animals.

Registry Number 8652

Date of notice confirming acceptance: August 22, 2013

The claimant had been advised to amend certain aspects of the content of the MSDS.

Registry Number 8653

Date of notice confirming acceptance: August 22, 2013

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. In relation to the first aid information shown on the MSDS for eye and skin contact, disclose an approximate flush time of 30 minutes.
  2. In relation to the first aid information shown on the MSDS for ingestion, disclose advice such as the following: should vomiting occur naturally, have the casualty lean forward in order to reduce the risk of aspiration.

Registry Number 8758

Date of notice confirming acceptance: October 31, 2013

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Add oxides of nitrogen to the list of hazardous decomposition products.

Registry Number 8778

Date of notice confirming acceptance: October 8, 2013

The claimant had been advised to amend the MSDS as indicated below.

  1. Add oxides of carbon and oxides of nitrogen to the list of hazardous decomposition products.

In the case of the following claims, either the claimant did not supply the screening officer with a signed undertaking or the screening officer was not satisfied that the claimant had taken the measures set out in the undertaking in the manner and within the period specified in it. Pursuant to subsection 17(1) of the Hazardous Materials Information Review Act, the screening officer ordered the claimant to comply with the requirements of the relevant legislation within 30 days from the expiry of the appeal period, except that the information in respect of which the claim for exemption was made does not have to be disclosed, and to provide a copy of the amended MSDS to the screening officer within 30 days of expiry of the appeal period.

CLAIMS FOR WHICH THE SCREENING OFFICER ORDERED THE CLAIMANT TO COMPLY WITH THE APPLICABLE DISCLOSURE REQUIREMENTS

Pursuant to paragraph 18(1)(a) of the Hazardous Materials Information Review Act, the Chief Screening Officer of the Workplace Hazardous Materials Directorate hereby gives notice of information that the screening officer ordered to be disclosed on a MSDS or label reviewed by the screening officer.

Registry Number 8250

Date of order: January 15, 2014

The claimant has been ordered to amend certain aspects of the content of the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

  1. Disclose the presence of two additional confidential hazardous ingredients in the controlled product together with their percent concentration, in an acceptable manner.
  2. Disclose that ingestion of an ingredient in the controlled product has been shown to cause fetotoxic effects in the presence of maternal toxicity in laboratory animals.
  3. Disclose an LD50 (oral, rat) value of 1.39 g/kg for the confidential hazardous ingredient “alkyl phosphate”.
  4. Disclose an LD50 (oral, rat) value of 1.26 g/kg and an LD50 (dermal, rabbit) value of 2.03 mL/kg for the confidential hazardous ingredient “glycol ether”.
  5. Disclose that chronic ingestion of an ingredient in the controlled product has been shown to cause bladder and hemolytic anemia effects in laboratory animals.

Registry Number 8352

Date of order: July 15, 2013

The claimant has been ordered to amend certain aspects of the content of the MSDS.

Registry Number 8355

Date of order: July 15, 2013

The claimant has been ordered to amend certain aspects of the content of the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

  1. In relation to the first aid information shown on the MSDS for eye and skin contact, disclose an approximate flush time of 30 minutes.
  2. In relation to the first aid information shown on the MSDS for ingestion, disclose advice such as the following: should vomiting occur naturally, have casualty lean forward in order to reduce the risk of aspiration.
  3. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to dilute contents of stomach using 4–10 fluid ounces of milk or water.
  4. Add oxides of carbon to the list of hazardous decomposition products.

Registry Number 8638

Date of order: August 26, 2013

The claimant has been ordered to amend certain aspects of the content and format of the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

  1. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D2A.

The following claims, 8448, 8568 and 8576, were cancelled after the issuance of the decisions but prior to the issuance of either a signed undertaking or signed orders. The screening officer has identified the following instances of non-compliance with the requirements of the relevant legislation.

Registry Number 8448

The screening officer determined that certain aspects of the content of the MSDS were required to be amended.

Registry Number 8568

The screening officer determined that amendments to the MSDS were required as indicated below.

  1. Add oxides of nitrogen to the list of hazardous decomposition products.
  2. Disclose an LC50 (aerosol, rat, 4 hours) value of 50–500 mg/m3 for the confidential hazardous ingredient “polymeric isocyanate”.
  3. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D1A.

Registry Number 8576

The screening officer determined that amendments to the MSDS were required as indicated below.

1. Disclose a lower LD50 (oral, female rat) value of 5 155 mg/kg for the hazardous ingredient “1-methoxy-2-propanol acetate”.

[8-1-o]

DEPARTMENT OF INDUSTRY

OFFICE OF THE REGISTRAR GENERAL

Appointments
Name and position Order in Council
Dedimus potestatem 2014-135
Commissioners to administer oaths  

Within Alberta

  

Anderson, The Hon. Charlene S.

  

Brown, The Hon. Russell S.

  

Campbell, The Hon. Glenda A.

  

Dario, The Hon. Corina

  

Nixon, The Hon. Kim D.

  

Pentelechuck, The Hon. Dawn

  

Schutz, The Hon. Frederica L.

  

Simpson, The Hon. Eldon J.

  

Wakeling, The Hon. Thomas W.

  

Within British Columbia

  

Baird, The Hon. Robin A. M.

  

Ball, The Hon. Kenneth W.

  

Donegan, The Hon. Sheri Ann

  

Fleming, The Hon. Margot L.

  

Funt, The Hon. Gordon S.

  

Harris, The Hon. Wendy J.

  

Skolrood, The Hon. Ronald A.

  

Steeves, The Hon. John J.

  

Thompson, The Hon. Douglas W.

  

Warren, The Hon. Lisa A.

  

Weatherill, The Hon. Gary

 

Within Canada

  

Graham, The Hon. David E.

  

Lyons, The Hon. Kathleen T.

  

Manson, The Hon. Michael D.

  

McVeigh, The Hon. Glennys L.

  

Roy, The Hon. Yvan

  

Strickland, The Hon. Cecily Y.

  

Within Manitoba

  

Edmond, The Hon. James G.

  

Hatch, The Hon. Gwen B.

  

Lanchberry, The Hon. Sheldon W.

  

Mainella, The Hon. Christopher J.

  

Within Newfoundland and Labrador

  

Burrage, The Hon. Donald H.

  

Hurley, The Hon. David F.

  

Within Nova Scotia

  

Arnold, The Hon. Joshua M.

  

Chipman, The Hon. James L.

  

Gogan, The Hon. Robin

  

Van den Eyden, The Hon. Elizabeth

  

Within Ontario

  

André, The Hon. Irving W.

  

Barnes, The Hon. Kofi N.

  

Chiappetta, The Hon. Victoria R.

  

Coroza, The Hon. Steve A.

  

Douglas, The Hon. Peter A.

  

Edwards, The Hon. David L.

  

Firestone, The Hon. Stephen E.

  

Garson, The Hon. Marc A.

  

Laliberté, The Hon. Ronald

  

Matheson, The Hon. Wendy

  

Nightingale, The Hon. Robert J.

  

Skarica, The Hon. Antonio

  

Tzimas, The Hon. E. Ria

  

Vallee, The Hon. Mary E.

  

Varpio, The Hon. Michael N.

  

Within Prince Edward Island

  

Key, The Hon. Nancy L.

  

Within Quebec

  

Beaulieu, The Hon. Daniel

  

Bellavance, The Hon. Pierre C.

  

Bergeron, The Hon. Lise

  

Blanchard, The Hon. Jacques

  

Bouchard, The Hon. Jacques G.

  

Bouchard, The Hon. Sandra

  

Brossard, The Hon. Christian J.

  

Dionne, The Hon. Louis

  

Di Salvo, The Hon. Hélène

  

Dulude, The Hon. France

  

Hamilton, The Hon. Stephen W.

  

Kear-Jodoin, The Hon. Karen L.

  

Labrie, The Hon. Pierre

  

Michaud, The Hon. Jean-François

  

Paradis, The Hon. J. Marc

  

Within Saskatchewan

  

Chow, The Hon. Darin C.

  

Elson, The Hon. Richard W.

  

Krogan-Stevely, The Hon. Lana L.

  

Zuk, The Hon. Lyle W.

  
Orsborn, The Hon. David B. 2014-140

Government of Newfoundland and Labrador

  

Administrator

  

February 25 to February 28, 2014

  

February 14, 2014

DIANE BÉLANGER
Official Documents Registrar

[8-1-o]

DEPARTMENT OF INDUSTRY

INVESTMENT CANADA ACT

Amount for the year 2014

Pursuant to subsection 14.1(2) of the Investment Canada Act, I hereby determine that the amount for the year 2014, equal to or above which an investment is reviewable, is three hundred and fifty-four million dollars.

JAMES MOORE
Minister of Industry and
Minister Responsible for Investment Canada

[8-1-o]

OFFICE OF THE SUPERINTENDENT OF FINANCIAL INSTITUTIONS

BANK ACT

China Construction Bank Corporation — Order permitting a foreign bank to establish a branch in Canada

Pursuant to subsection 524(1) of the Bank Act, the Minister of Finance made an order on January 31, 2014, permitting China Construction Bank Corporation to establish a branch in Canada to carry on business in Canada under the name, in English, China Construction Bank Toronto Branch and, in French, Banque de construction de Chine succursale de Toronto.

February 19, 2014

JULIE DICKSON
Superintendent of Financial Institutions

[8-1-o]